Delisting riskPopularity #4,865
ALZN · NASDAQ · Biotechnology

Alzamend Neuro (ALZN)

Develops AL001 and ALZN002 candidates for Alzheimer’s disease and psychiatric disorders.

$1.94
vs last close−0.00 (−0.26%)